© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com
Virios Therapeutics, Inc. (VIRI) stock surged +12.40%, trading at $0.16 on NASDAQ, up from the previous close of $0.14. The stock opened at $0.21, fluctuating between $0.14 and $0.21 in the recent session.
Virios Therapeutics, Inc., a development-stage biotechnology company, focuses on developing antiviral therapies to treat diseases associated with a viral triggered abnormal immune response. The company's lead development candidate is the IMC-1, a fixed dose combination of famciclovir and celecoxib to treat fibromyalgia. It is also developing IMC-2, a combination of valacyclovir and celecoxib for the treatment of managing the fatigue, sleep, attention, pain, autonomic function, and anxiety associated with long COVID. The company was formerly known as Virios Therapeutics, LLC and changed its name to Virios Therapeutics, Inc. in December 2020. Virios Therapeutics, Inc. was founded in 2012 and is headquartered in Alpharetta, Georgia.
Employees | 4 |
Beta | 1.58 |
Sales or Revenue | $0.00 |
5Y Sales Change% | 0% |
Fiscal Year Ends | December |
Sector | Healthcare |
Industry | Biotechnology |
Virios Therapeutics, Inc. (NASDAQ: VIRI) stock price is $0.16 in the last trading session. During the trading session, VIRI stock reached the peak price of $0.21 while $0.14 was the lowest point it dropped to. The percentage change in VIRI stock occurred in the recent session was 12.4% while the dollar amount for the price change in VIRI stock was $0.02.
The NASDAQ listed VIRI is part of Biotechnology industry that operates in the broader Healthcare sector. Virios Therapeutics, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.
Mr. Gregory Duncan
Chairman & Chief Executive Officer
Ms. Angela Walsh
Chief Financial Officer, SVice President of Fin., Corporation Sec. & Treasurer
Ms. Carol Duffy Ph.D.
Chief Scientific Advisor
Mr. Ralph D. Grosswald M.P.H.
Senior Vice President of Operations
Dr. R. Michael Gendreau M.D., Ph.D.
Chief Medical Officer
Dr. William L. Pridgen M.D.
Founder & Director
VIRI's closing price is 8.39% higher than its 52-week low of $0.14 where as its distance from 52-week high of $26.00 is -99.4%.
Number of VIRI employees currently stands at 4.
Official Website of VIRI is: https://www.virios.com
VIRI could be contacted at phone 866 620 8655 and can also be accessed through its website. VIRI operates from 44 Milton Avenue, Alpharetta, GA 30009, United States.
VIRI stock volume for the day was 42.36M shares. The average number of VIRI shares traded daily for last 3 months was 87.79K.
The market value of VIRI currently stands at $206.50K with its latest stock price at $0.16 and 1.33M of its shares outstanding.